Experience of percutaneous tracheostomy in critically ill COVID-19 patients
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Coronavirus disease 2019 (COVID-19) is a highly contagious disease that causes respiratory failure. Tracheostomy is an essential procedure in critically ill COVID-19 patients; however, it is an aerosol-generating technique and thus carries the risk of infection transmission. We report our experience with percutaneous tracheostomy and its safety in a real medical setting. Methods: During the COVID-19 outbreak, 13 critically ill patients were admitted to the intensive care unit (ICU) at Daegu Catholic University Medical Center between February 24 and April 30, 2020. Seven of these patients underwent percutaneous tracheostomy using Ciaglia Blue Rhino. The medical environment, percutaneous tracheostomy method, and COVID-19 reverse transcriptase-polymerase chain reaction (RT-PCR) results were retrospectively reviewed. After treatment, the COVID-19 infection status of healthcare personnel was investigated by RT-PCR. Results: The ICU contained negative pressure cohort areas and isolation rooms, and healthcare personnel wore a powered air-purifying respirator system. We performed seven cases of percutaneous tracheostomy in the same way as in patients without COVID-19. Five patients (71.4%) tested positive for COVID-19 by RT-PCR at the time of tracheostomy. The median cycle threshold value for the RNA-dependent RNA polymerase was 30.60 (interquartile range [IQR], 25.50–36.56) in the upper respiratory tract and 35.04 (IQR, 28.40–36.74) in the lower respiratory tract. All healthcare personnel tested negative for COVID-19 by RT-PCR. Conclusions: Percutaneous tracheostomy was performed with conventional methods in the negative pressure cohort area. It was safe to perform percutaneous tracheostomy in an environment of COVID-19 infection.
Abstract
Background: Coronavirus disease 2019 (COVID-19) is a highly contagious disease that causes respiratory failure. Tracheostomy is an essential procedure in critically ill COVID-19 patients; however, it is an aerosol-generating technique and thus carries the risk of infection transmission. We report our experience with percutaneous tracheostomy and its safety in a real medical setting. Methods: During the COVID-19 outbreak, 13 critically ill patients were admitted to the intensive care unit (ICU) at Daegu Catholic University Medical Center between February 24 and April 30, 2020. Seven of these patients underwent percutaneous tracheostomy using Ciaglia Blue Rhino. The medical environment, percutaneous tracheostomy method, and COVID-19 reverse transcriptase-polymerase chain reaction (RT-PCR) results were retrospectively reviewed. After treatment, the COVID-19 infection status of healthcare personnel was investigated by RT-PCR. Results: The ICU contained negative pressure cohort areas and isolation rooms, and healthcare personnel wore a powered air-purifying respirator system. We performed seven cases of percutaneous tracheostomy in the same way as in patients without COVID-19. Five patients (71.4%) tested positive for COVID-19 by RT-PCR at the time of tracheostomy. The median cycle threshold value for the RNA-dependent RNA polymerase was 30.60 (interquartile range [IQR], 25.50–36.56) in the upper respiratory tract and 35.04 (IQR, 28.40–36.74) in the lower respiratory tract. All healthcare personnel tested negative for COVID-19 by RT-PCR. Conclusions: Percutaneous tracheostomy was performed with conventional methods in the negative pressure cohort area. It was safe to perform percutaneous tracheostomy in an environment of COVID-19 infection.
참고문헌 (28)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- Chen N, "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China : a descriptive study", Lancet, 395, pp.507~513 (2020)
- Wang D, "Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China", JAMA, 323, pp.1061~1069 (2020)
- Guan WJ, "Clinical characteristics of coronavirus disease 2019 in China", N Engl J Med, 382, pp.1708~1720 (2020)
- Zhou F, "Clinical course and risk factors for mortality of adult inpatients with COVID-19in Wuhan, China : a retrospective cohort study", Lancet, 395, pp.1054~1062 (2020)
- Li X, "Acute respiratory failure in COVID-19: is it “typical”ARDS?", Crit Care, 24, pp.198~ (2020)
- Tay JK, "Surgical considerations for tracheostomy during the COVID-19 pandemic : lessons learned from the severe acute respiratory syndrome outbreak", JAMA Otolaryngol Head Neck Surg, 146, pp.517~518 (2020)
- McGrath BA, "Tracheostomy in the COVID-19 era : global and multidisciplinary guidance", Lancet Respir Med, 8, pp.717~725 (2020)
- Ahmed N, "Open tracheostomy in a suspect severe acute respiratory syndrome(SARS)patient : brief technical communication", Can J Surg, 48, pp.68~71 (2005)
- Kwan A, "Tracheostomy in a patient with severe acute respiratory syndrome", Br J Anaesth, 92, pp.280~282 (2004)
- Wei WI, "Safe tracheostomy for patients with severe acute respiratory syndrome", Laryngoscope, 113, pp.1777~1779 (2003)
- 송주헌, "중동호흡기증후군 환자에 시행한 기관절개술 1예", 임상이비인후과, 26(2), pp.301~306 (2015), 대한이비인후과학회 부산,울산,경남 지부회[DOI]
- Takhar A, "Recommendation of a practical guideline for safe tracheostomy during the COVID-19 pandemic", Eur Arch Otorhinolaryngol, 277, pp.2173~2184 (2020)
- "AAO position statement: tracheotomy recommendations during the COVID-19 pandemic" (2020)[URL]
- "Recommendations from the CSO-HNS taskforce on performance of tracheotomy during the COVID-19 pandemic" (2020)[URL]
- Lee SY, "Crucial role of temporary airborne infection isolation rooms in an intensive care unit : containing the COVID-19 outbreak in South Korea", Crit Care, 24, pp.238~ (2020)
- Ambesh SP, "Percutaneous tracheostomy with single dilatation technique : a prospective, randomized comparison of Ciaglia blue rhino versus Griggs’ guidewire dilating forceps", Anesth Analg, 95, pp.1739~1745 (2002)
- Zhang X, "Safe and effective management of tracheostomy in COVID-19 patients", Head Neck, 42, pp.1374~1381 (2020)
- Angel L, "Novel percutaneous tracheostomy for critically ill patients with COVID-19", Ann Thorac Surg, 110, pp.1006~1011 (2020)
- Vargas M, "Modified percutaneous tracheostomy in COVID-19 critically ill patients", Head Neck, 42, pp.1363~1366 (2020)
- Al Yaghchi C, "Percutaneous tracheostomy in patients with COVID-19 : sealing the bronchoscope with an in-line suction sheath", Br J Anaesth, 125, pp.e185~e186 (2020)
- Heikkinen M, "Percutaneous dilational tracheostomy or conventional surgical tracheostomy?", Crit Care Med, 28, pp.1399~1402 (2000)
- Dulguerov P, "Percutaneous or surgical tracheostomy : a meta-analysis", Crit Care Med, 27, pp.1617~1625 (1999)
- Pauliny M, "Percutaneous dilation tracheostomy versus surgical tracheostomy in critically ill patients", Bratisl Lek Listy, 113, pp.409~411 (2012)
- Salna M, "tracheostomy is safe during extracorporeal membrane oxygenation support", ASAIO J, 66, pp.652~656 (2020)
- Dimopoulos S, "Safety of percutaneous dilatational tracheostomy during veno-venous extracorporeal membrane oxygenation support in adults with severe respiratory failure", Crit Care Med, 47, pp.e81~e88 (2019)
- Mi Seon Han, "RT-PCR for SARS-CoV-2: quantitative versus qualitative", Lancet Infect Dis (2020), Elsevier BV[DOI]
- Fang Y, "Sensitivity of chest CT for COVID-19 : comparison to RT-PCR", Radiology, 296, pp.E115~E117 (2020)